About 40% of U.S. adults are obese according to the CDC, and excess weight increases the risk of type 2 diabetes, hypertension, heart disease, sleep apnea, and joint pain. In the SURMOUNT-1 clinical study, participants on tirzepatide plus diet and exercise achieved an average weight loss of 15% to 21% over 72 weeks, compared with about 3% on placebo. Results vary for each person.

What we do: We evaluate if you are a candidate, provide medical follow-up and apply one injection per week, starting at $49.99 per application.

Call the clinic